Smart AI system for diagnosing multiple eye diseases
Part of Eyes & vision clinical trials.
This trial uses a smart computer system to help diagnose multiple eye diseases by looking at your eye scans. You may qualify if you have one of the listed eye conditions and your scans are clear enough for the AI to analyze.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with a specific eye disease like macular degeneration, diabetic macular edema, or glaucoma (and a few others).
- You have had clear, high-quality eye scans (SS-OCT or SS-OCTA images).
- Your scans were not blurry or hard to read because of eye problems like cataracts or poor cooperation.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses artificial intelligence to analyze eye images and help doctors diagnose eye diseases. It looks at images from routine care to train and test the AI system.
This research tests whether a computer program can help doctors diagnose eye diseases using special scans called OCT. If you have a common retinal condition and have had these scans, you may be eligible to help improve how eye diseases are found.
This trial tests an artificial intelligence tool that may help detect glaucoma earlier. It compares AI analysis of eye images between people with glaucoma and healthy volunteers.
This trial tests whether giving doctors an AI second opinion on retinal scans helps them make better treatment decisions for people with a specific eye disease called nAMD. It's a short, one-time study for eye doctors, not for patients.
This trial tests a new artificial intelligence system that helps eye doctors make decisions. You may qualify if you are having a routine eye exam and can get clear images of both eyes.
This study tests how well an AI system can diagnose retinal diseases from eye photos. It might help if you need a quick and accurate diagnosis using standard eye imaging.
Hear when a new Glaucoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.